InterMune prices Esbriet in Germany and Norway and raises $231m in equity and loans
15 September 2011
Pial Ganguli
Please Login to read the full article.
15 September 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- GNI gains first approval for lead product pirfenidone, in China for IPF
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
- Promedior's new $21.5M series D helps advance fibrosis portfolio, including IPF and mylelofibrosis
- Triple therapy for IPF worse than placebo
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
